Rationale, design and baseline characteristics of a clinical trial comparing the effects of robust vs conventional cholesterol lowering and intima media thickness in patients with familial hypercholesterolaemia: The atorvastatin versus simvastatin on atherosclerosis progression (ASAP) study

Clinical Drug Investigation

Volumn 20, Issue 2, 2000, Pages 67-79

  Smilde, T J ^a   Trip, M D ^b   Wollersheim, H ^a   Van Wissen, S ^b   Kastelein, J J P ^b   Stalenhoef, A F H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FEMORAL ARTERY; HUMAN; INTIMA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEX DIFFERENCE; SMOKING; THICKNESS; TREATMENT OUTCOME;

EID: 0033858562     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200020020-00001     Document Type: Article

References (49)

1. Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging
2. Association of carotid atherosclerosis with electrocardiographic myocardial ischemia and left ventricular hypertrophy
3. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease
4. Carotid atherosclerosis measured by B-mode ultrasound in populations; associations with cardiovascular risk factors in the ARIC study
5. Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group
6. High-resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities Study (ARIC)
7. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. A new model for the quantitation and follow-up of pre clinical atherosclerosis in living human subjects
8. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: A case control study
9. Measurement of intima media thickness of common carotid arteries with high-resolution B-mode ultrasonography: Inter- and intra-observer variability
10. Non invasive quantification of atherosclerotic lesions. Reproducibility of ultrasonographic measurement of arterial wall thickness and plaque size
11. Use of monitoring software to improve the measurement of carotid wall thickness by B-mode imaging
12. Reproducibility of carotid vessel wall thickness measurements. The Rotterdam Study
13. Reproducibility of ultrasonographic measurements of different carotid and femoral artery segments in healthy subjects and in patients with increased intima media thickness
14. Calcium antagonist and atherosclerosis. Multicenter Isradipine/Diuretic Atherosclerosis Study
15. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy. A randomized, controlled clinical trial
16. Effects of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease
17. Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and 4-year reduction of intima-media thickness measured by ultrasound
18. Effect of Lovastatin on early carotid atherosclerosis and cardiovascular events
19. Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)
20. A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries
21. One year reduction and longitudinal analysis of carotid intima media thickness associated with colestipol/niacin therapy
22. Beneficial effects of colestipol-niacin therapy on the common carotid artery
23. Reduction of carotid artery intima media thickness with lipid lowering therapies: A comparison of two clinical trials
24. Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: A report from the regression growth evaluation statin study
25. Arterial wall thickness in familia hypercholesterolemia. Ultrasound measurement of intima media thickness in the common carotid artery
26. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima-media thickness and plaque occurrence
27. Carotid and femoral wall thickness and stiffness in patients at risk for cardiovascular disease, with special emphasis on hyperhomocysteinemia
28. Carotid intima media thickness and plaque in patients with familial hypercholesterolemia mutations and control subjects
29. The extracranial carotid artery in familial hypercholesterolemia: Relationship of intimal media thickness and plaques morphology with plasma lipids and coronary heart disease
30. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens
31. Drug therapy for hypercholesterolemia in patients with cardiovascular disease: Factors limiting achievement of lipid goals
32. Randomized trial of cholesterol owering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
33. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)
34. Reduction of LDL cholesterol by 25-60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor
35. A study of the use of polyethylene glycol in estimating cholesterol in high density lipoprotein
36. Detection and quantitation of calcific atherosclerosis by ultra fast computed tomography in children and young adults with homozygous familial hypercholesterolemia
37. Carotid artery intima media thickness as an indicator of generalized atherosclerosis
38. Association of coronary disease with segment-specific intimal medial thickening of extracranial carotid artery
39. Common carotid intima media thickness and risk of stroke and myocardial infarction: The Rotterdam Study
40. Atherosclerotic changes of extracoronary arteries are associated with the extent of coronary atherosclerosis
41. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults
42. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) study, 1987-1993
43. The role of carotid arterial intima media thickness in predicting clinical coronary events
44. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults Summary of the second report of the national cholesterol education program (NCEP) expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
45. Together with members of the task force.Task force report. Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
46. Atorvastatin: An effective lipid-modifying agent in familial hypercholesterolemia
47. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, Iovastatin, and fluvastatin in patients with hypercholesterolemia (the curves study)
48. Percentage change rather than plasma level of LDL cholesterol determines therapeutic response in coronary heart disease
49. The Post Coronary Artery Bypass Graft trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass graft